Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysisWon‐Mook Choi, Young‐Suk Lim, Yi‐Hsiang Huang et al.|Journal of Hepatology|2022Cited by 62
Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in TaiwanChen‐Hua Liu, Jia‐Horng Kao, Ming‐Lung Yu et al.|Alimentary Pharmacology & Therapeutics|2018Cited by 52
Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patientsWon‐Mook Choi, Young‐Suk Lim, Terry Cheuk‐Fung Yip et al.|Hepatology|2024Cited by 33
Baseline Viral Load and On-Treatment Hepatocellular Carcinoma Risk in Chronic Hepatitis B: A Multinational Cohort StudyWon‐Mook Choi, Young‐Suk Lim, Terry Cheuk‐Fung Yip et al.|Clinical Gastroenterology and Hepatology|2024Cited by 16
Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE studyChen-Hua Liu, Jia‐Horng Kao, Ming‐Lung Yu et al.|Journal of the Formosan Medical Association|2018Cited by 10